The short version
14 companies supply this market — deep enough that no single failure threatens the supply.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Medroxyprogesterone Acetate
Medroxyprogesterone Acetate · MEDROXYPROGESTERONE ACETATE 10 mg/1 · Tablet · Oral · Preferred Pharmaceuticals, Inc.
NDC 68788-9899-01 · 10 TABLET in 1 BOTTLE · ANDA · View full market →
Medicare Part D
All Part D pricing →Matched to CMS's representative package for this drug (NDC 00555-0779-02) — same generic, strength, and dosage form. CMS prices one NDC per drug concept, not every package.
ⓘ How this was built
Data sources
- CMS quarterly Prescription Drug Plan Formulary & Pricing files (SPUF)
Method
Negotiated 30-day point-of-sale unit prices and formulary terms aggregated across every unsuppressed Part D and MA-PD plan for the quarter shown. Point of sale means gross of confidential rebates. CMS publishes one representative NDC per drug concept (RxCUI) rather than every package, so these figures come from CMS's representative package for the same drug — matched on generic name, strength, and dosage form. Estimated from MedPAC's program-wide rebate aggregates (June 2023: DIR = 29% of gross Part D spending; brand rebates ≈ 25–40% of gross, generics minimal). Actual rebates are confidential and vary widely by drug — this is a range, not a fact about this drug.
Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.
Plans pay at point of saleⓘ
$0.2354per unit
middle half $0.1339–$0.2810 · 5,496 plans · Apr 1, 2026
Est. net of rebatesⓘ
≈ $0.2354
generic — rebates are minimal, so net ≈ gross
Coverage & restrictions
100%of plans cover it
tier 1 · prior auth 0% · step therapy 0% · qty limit 0%
*No drug-level rebate is public — the estimate applies MedPAC's program-wide brand rebate range to this drug's gross price. Tracked here for 10 quarters since 2024.
NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
90-day shortage risk (model v2)
0.1%chance of a new FDA shortage posting for medroxyprogesterone acetate (oral solid) in the next 90 days
sole-source market
For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.
Backtested statistical model over the whole market, not this package alone. Model details →
Regulatory
- Application
- ANDA040159
- TE code
- AB
- Approval date
- Aug 9, 1996
- Patents / exclusivity
- None on file
Shortage history
- Planned discontinuation — PROVERA, Tablet, 10 mg (NDC 0009-0051-01)Aug 31, 2026
- Planned discontinuation — PROVERA, Tablet, 2.5 mg (NDC 0009-0065-01)Aug 31, 2026
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Medroxyprogesterone Acetate (Tablet)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| A-S Medication Solutions | MEDROXYPROGESTERONE ACETATE 2.5 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| A-S Medication Solutions | MEDROXYPROGESTERONE ACETATE 10 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| A-S Medication Solutions | MEDROXYPROGESTERONE ACETATE 5 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| American Health Packaging | MEDROXYPROGESTERONE ACETATE 10 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Bryant Ranch Prepack | MEDROXYPROGESTERONE ACETATE 5 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Bryant Ranch Prepack | MEDROXYPROGESTERONE ACETATE 2.5 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Coupler LLC | MEDROXYPROGESTERONE ACETATE 2.5 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Mylan Pharmaceuticals Inc. | MEDROXYPROGESTERONE ACETATE 10 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Mylan Pharmaceuticals Inc. | MEDROXYPROGESTERONE ACETATE 5 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Mylan Pharmaceuticals Inc. | MEDROXYPROGESTERONE ACETATE 2.5 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Northwind Health Company, LLC | MEDROXYPROGESTERONE ACETATE 10 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| NuCare Pharmaceuticals,Inc. | MEDROXYPROGESTERONE ACETATE 10 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| PD-Rx Pharmaceuticals, Inc. | MEDROXYPROGESTERONE ACETATE 2.5 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| PD-Rx Pharmaceuticals, Inc. | MEDROXYPROGESTERONE ACETATE 10 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Pharmacia & Upjohn Company LLC | MEDROXYPROGESTERONE ACETATE 5 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Pharmacia & Upjohn Company LLC | MEDROXYPROGESTERONE ACETATE 10 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Pharmacia & Upjohn Company LLC | MEDROXYPROGESTERONE ACETATE 2.5 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Preferred Pharmaceuticals Inc. | MEDROXYPROGESTERONE ACETATE 5 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Preferred Pharmaceuticals, Inc. | MEDROXYPROGESTERONE ACETATE 10 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Proficient Rx LP | MEDROXYPROGESTERONE ACETATE 10 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Remedyrepack Inc. | MEDROXYPROGESTERONE ACETATE 2.5 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Remedyrepack Inc. | MEDROXYPROGESTERONE ACETATE 10 mg/1 | Jul 22, 2026 | Sep 2, 2026 |
| Teva Pharmaceuticals USA, Inc. | MEDROXYPROGESTERONE ACETATE 5 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Teva Pharmaceuticals USA, Inc. | MEDROXYPROGESTERONE ACETATE 10 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Teva Pharmaceuticals USA, Inc. | MEDROXYPROGESTERONE ACETATE 2.5 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Bryant Ranch Prepack | MEDROXYPROGESTERONE ACETATE 10 mg/1 | Jul 15, 2026 | Aug 31, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Medroxyprogesterone Acetate — NDC 68788-9899-01," retrieved September 3, 2026, https://drugdashboards.com/drug/68788989901.
Free to cite with attribution — see how the data is put together.